Quotient Sciences is a leading drug development services provider, focused on helping our clients reduce the time and cost of bringing a drug to market. We work with many of the leading biotech and pharmaceutical companies worldwide and can integrate drug substance manufacturing, dryg product manufacturing, and clinical pharmacology services typically sourced from multiple CDMO and CRO vendors in a single program of work.

We have completed over 1,300 Phase 1 trials and can support our clients by working under FDA (Food and Drug Administration) or MHRA (Medicines & Healthcare products Regulatory Agency) guidelines.